Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm
FDA: Guidance for Industry Duchenne Muscular Dystrophy Developing Drugs for Treatment Over the Spectrum of Disease
CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia July 23, 2015 CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia Austin, TX – 23 Ju
Critical Path Institute Establishes The Global Pediatric Clinical Trials Network Pre-Launch Consortium July 22, 2015 Critical Path Institute Establishes The Global Pediatric Clinical Trials Network Pre-Launch Con
June 26, 2015 Patient-Centered Research To Support The Development Of The Symptoms Of Major Depressive Disorder Scale (SMDDS): Initial Qualitative Research
Critical Path Institute Announces Appointments of Peter Hutt, Alan Levin, and Paula Olsiewski To Its Board of Directors June 25, 2015 Critical Path Institute Announces Appointments of Peter Hutt, Alan Levin, and Paula Olsiewski To Its Board of Direc
